COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-11 01:00 |
Cosmo ernennt Andrea Cherubini zum Chief AI Officer, um die KI-Expansion im ge…
|
German | 9.0 KB | ||
| 2025-02-10 01:00 |
Cosmo and Glenmark Announces UK MHRA Approval of Winlevi® for Treatment of Acne
|
English | 10.5 KB | ||
| 2025-02-10 01:00 |
Cosmo und Glenmark geben die Genehmigung der britischen Arzneimittelbehörde MHR…
|
German | 11.6 KB | ||
| 2025-01-28 01:00 |
Invitation to Cosmo’s Unaudited Full Year 2024 Financial Results Webcast on 6 M…
|
English | 7.2 KB | ||
| 2025-01-28 01:00 |
Einladung zur Web-Präsentation der ungeprüften Finanzergebnisse von Cosmo für d…
|
German | 7.8 KB | ||
| 2025-01-09 01:00 |
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Prov…
|
English | 11.2 KB | ||
| 2025-01-09 01:00 |
Cosmo Pharmaceuticals gibt starke Umsätze und Barmittel für 2024 bekannt und pr…
|
German | 12.7 KB | ||
| 2024-12-12 01:00 |
Cosmo Pharmaceuticals appoints Chief Strategy Officer
|
English | 8.1 KB | ||
| 2024-12-12 01:00 |
Cosmo Pharmaceuticals ernennt Chief Strategy Officer
|
German | 9.2 KB | ||
| 2024-10-18 02:00 |
Cosmo shareholders approved Board proposal to appoint new independent auditor …
|
English | 5.5 KB | ||
| 2024-10-18 02:00 |
Cosmo-Aktionäre genehmigen an heutiger a.o. GV den Vorschlag des Verwaltungsrat…
|
German | 6.0 KB | ||
| 2024-10-11 02:00 |
Cosmo Pharmaceuticals appoints new Chief Financial Officer
|
English | 7.6 KB | ||
| 2024-10-11 02:00 |
Cosmo Pharmaceuticals ernennt neue Finanzchefin
|
German | 8.8 KB | ||
| 2024-09-23 02:00 |
Cosmo Pharmaceuticals enhances Management Team with newly appointed Head of Gl…
|
English | 7.1 KB | ||
| 2024-09-23 02:00 |
Cosmo Pharmaceuticals erweitert Management Team mit neu ernannter Head of Globa…
|
German | 8.0 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
